- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 68.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 68.91M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 68.91M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$60.04K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$63.99K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $121.9K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $94.56K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$957.23K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$892.47K |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$644.38K |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$561.39K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.01M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $1.1M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.01M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $139.24K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $112.23K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $143.29K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $116.85K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.00 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.00 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$64.76K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$82.98K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$58.94K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$82.98K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $6.88K |